Last Updated on July 9, 2026 by Staff
As women grow older their fertility naturally declines due to several biological changes. The quality of their eggs decreases, the number of healthy follicles drops and ovarian tissues gradually become harder. These age-related changes make it more difficult to get pregnant naturally. Many women now delay pregnancy until their 30s or 40s because of education, careers or personal choices. This has made infertility a big global health issue.
Current fertility treatments, like hormone therapy and in vitro fertilization (IVF) mainly focus on stimulating egg production or helping fertilization occur. However these methods do not directly address one of the causes of age-related infertility—the physical aging and stiffening of the ovaries.
A groundbreaking study published in Nature Aging suggests a new approach. By focusing only on eggs or hormones researchers discovered that softening aging ovarian tissue could significantly improve fertility. Their findings may eventually lead to treatments that help women remain fertile for longer.
Why Ovaries Harden
The research was led by Shixuan Wang and his team at Huazhong University of Science and Technology in Wuhan, China. They wanted to understand why ovaries become stiffer with age and whether reversing this process could improve fertility.
The researchers collected ovarian tissue samples from young middle-aged and older women. They also looked at tissues from patients with conditions like polycystic ovary syndrome (PCOS) premature ovarian insufficiency (POI) and endometriosis.
After analyzing the tissues the team found that aging and diseased ovaries had higher levels of a protein called interleukin-11 (IL-11). This inflammatory protein seemed to be linked with ovarian aging.
The researchers thought that IL-11 might be responsible for making tissues harder over time.
The Hidden Culprit
To test their theory scientists grew fibroblast cells in the lab. Fibroblasts are cells that produce tissue that supports organs.
When these cells were exposed to interleukin-11 they started producing much collagen. While collagen is a protein, too much of it causes tissues to become rigid and scar-like.
As collagen accumulated the ovarian tissue became stiffer reducing its ability to function normally.
This discovery suggested that chronic inflammation caused by IL-11 may play a role in ovarian aging. Of simply being a natural consequence of getting older, tissue hardening may actually result from specific biological pathways that can be controlled.
The finding opened the possibility that blocking IL-11 could slow or even reverse some aspects of aging.
Animal Study Results
The researchers then tested their theory using modified mice that couldn’t respond to interleukin-11.
The results were remarkable. Compared to mice the genetically modified animals showed much less ovarian stiffening as they aged. Their ovaries remained healthier. Continued functioning more effectively for longer periods.
Scientists also looked at mouse models representing chemotherapy-induced ovarian insufficiency and polycystic ovary syndrome. In both cases blocking IL-11 reduced ovarian damage and improved reproductive function. These experiments strongly suggested that the inflammatory protein is directly involved in deterioration.
A New Fertility Treatment
In the stage of the study researchers developed a treatment using nanoparticles that carried small interfering RNA (siRNA). This advanced genetic technology works by switching off the IL-11 gene preventing the body from producing amounts of the inflammatory protein.
Older mice and rats received injections containing these nanoparticles. After treatment their ovaries became noticeably softer, healthier and more functional. The improvements in fertility were significant. Among mice pregnancy rates doubled from 25% to 50%. The treated animals also gave birth to litter rather than untreated mice. Similar improvements were observed in rats with more females becoming pregnant and producing offspring. These results suggest that targeting IL-11 could become a strategy for treating age-related infertility.
Future Possibilities
Although the research is still in its stages and has only been tested in animals, scientists believe it represents a breakthrough in reproductive medicine.
Unlike existing fertility treatments that mainly support egg maturation or fertilization this new approach aims to slow the aging of the ovaries themselves. By keeping tissue soft and healthy women may eventually be able to preserve fertility for a longer period. Researchers emphasize that extensive clinical trials will be required before the treatment can be tested safely in humans. They must confirm that blocking IL-11 does not produce side effects and that the therapy remains effective over the long term.
If future studies prove successful anti-IL-11 therapy could transform fertility treatment by addressing one of the root causes of aging. The discovery offers hope for millions of women who wish to delay pregnancy while preserving their natural reproductive potential.